Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

2013 to 2021 Saw Decline in Benzodiazepine Initiation Post-AIS

From 2013 to 2021, there was a decline in benzodiazepine initiation for post-acute ischemic stroke (AIS), according to a study published online Oct. 17 in Strok

Vaping Rates Hit Record Lows for U.S. High School Students

Is vaping finally losing its coolness for American teens The latest tally of federal data finds that 550,000 school kids, mostly high schoolers, quit using e-ci

Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

Novavax, Inc. (Nasdaq NVAX), a global company advancing protein-based vaccines with its Matrix-M adjuvant, today announced that the U.S. Food and Drug Administr

Kidney Transplants Safe When Donor, Recipient Both HIV-Positive

21 and 24 , respectively, after three years, the researchers reported. Other surgical complications, including side effects, also showed few differences.The onl

New Combo Drug Therapy Halves Death Risk From Advanced Hodgkin Lymphoma

those aged 60 and above.According to Friedberg, who spoke in the University of Rochester interview, progress against Hodgkin lymphoma has been one of cancer res

IDSA: 1999 to 2019 Saw Decrease in Sepsis-Related Mortality Rate in Children

From 1999 to 2019, there was a decrease in the sepsis-related mortality rate (SRMR) in children overall and across demographic groups, according to findings pre

Ultraprocessed Food Intake Accounts for More Than Half of Kids’ Energy Intake

Ultraprocessed food (UPF) intake accounts for nearly half of toddlers energy and increases in mid-childhood, according to a study published online Oct. 4 in the

Progression-Free Survival Improved With Nivolumab + AVD in Hodgkin Lymphoma

For patients with stage III or IV Hodgkin lymphoma, nivolumab with doxorubicin, vinblastine, and dacarbazine (N AVD) yields longer progression-free survival (PF

Risk for Most Cardiovascular Events Reduced After COVID-19 Vaccination

COVID-19 vaccination is associated with a reduced risk for most cardiovascular events, but with slightly increased risks of extrasystoles and transient ischemic

Substantial Mortality Benefits Expected From Optimal Medication Use for HFrEF

For individuals with heart failure with reduced ejection fraction (HFrEF), substantial mortality benefits would result from optimal use of guideline-directed me

Popular Keywords